Hydralazine also prevented angiotensin II-induced expression of Ccr2, and its ligands Ccl2 and Ccl8, consistent with Ccr2-mediated immune cell infiltration as a key aspect of brain inflammation during hypertension. Here, CCR2 is linked to hypertensive disorder.